New HRRS Solution CaCl2 0.025M neutralizing UFH
Solution of calcium chloride CaCl2 0.025M which neutralizes the effect of unfractionated heparins UFH on the TCA, KCT, SACT or NAPTT tests.
New Very Low VIII Control Plasma
Control plasma to measure the accuracy of the quantitative determination of Factor VIII in hemostasis for a very low value.
New CRYOcheck™ Hex LA™
CRYOcheck™ Hex LA™ is a qualitative test kit to aid in the detection of lupus anticoagulant (LA) by the application of hexagonal phase phospholipids.
New CRYOcheck™ Chromogenic FVIII
CRYOcheck™ Chromogenic Factor VIII is used for the colorimetric quantitative determination of Factor VIII activity in citrated human plasma.
New CRYOcheck™ Factor VIII Inhibitor Kit
This kit, intended for use in the clinical laboratory, serves to standardize the preparation of samples for the assay of inhibitors by the modified Bethesda-Nijmegen method. This kit is the ideal solution for laboratories wishing to use standardized sample preparations in order to limit the variability of anti-FVIII antibody assays.
New DOAC-Stop™
Suppresses all types of NOAC, including dabigatran, apixaban, rivaroxaban and edoxaban, with minimal effect on currently known coagulation variables.
New Synthetic Phospholipid Blend II
Mixture of highly purified procoagulant phospholipids for dilution.
New Senova Von Willebrand Factor Propeptide ELISA
The VWF : PP ELISA kit is intended for the quantitative enzyme immunoassay of von Willebrand factor propeptide (VWF: PP) in plasma.
New T-TAS® 01 Instrument
Microfluidic system on a chip (AR, PL and HD Chip) to quantify the process of thrombus formation under flow conditions.
